Astrazeneca: London-listed pharma giant heralds successful new breast cancer drug
Published
Astrazeneca has found that Enhertu helped patients live longer without their breast cancer getting worse compared to standard chemotherapy.
Full ArticlePublished
Astrazeneca has found that Enhertu helped patients live longer without their breast cancer getting worse compared to standard chemotherapy.
Full Article